Trump backer busted in Aussie biotech bungle

Outsider/

10 August 2018
| By Outsider |
image
image image
expand image

It would seem that when you’re a US Congressman, sitting down with your son to have “the drug talk” can mean something entirely different to what takes place over a suburban kitchen table.

Instead of the usual speeches of “don’t drink and drive” or “there’s a time and place for doing everything … and it’s called university,” Rep. Christopher Collins of New York allegedly told his son something more along the lines of: “The drug-trial results from this Aussie biotech mob, upon whose board I sit by the way, came back negative. Wanna dump 1.4 million shares?”

According to reports, Collins was arrested on federal charges relating to securities fraud last week in a case involving Australian biotech Innate Immunotherapeutics (try saying that three times, really quickly, under water, with a mouth full of marbles.)

A Securities and Exchange Commission complaint against Collins — the first congressional Republican to endorse Trump’s bid for the White House — also details charges against his son Cameron and the father of his son’s girlfriend, Stephen Zarsky. All three have pleaded not guilty to the charges against them.

The SEC complaint says that in June 2017, Rep. Collins passed on non-public information about Innate Immunotherapeutics’ unexpectedly negative drug-trial results to his son. The case says that Cameron Collins sold nearly 1.4 million shares based on non-public information.

The Collins’s next father-son fishing trip will most likely be postponed.

 

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

The succession dilemma is more than just a matter of commitments.This isn’t simply about younger vs. older advisers. It’...

3 months 1 week ago

Significant ethical issues there. If a relationship is in the process of breaking down then both parties are likely to b...

4 months ago

It's not licensees not putting them on, it's small businesses (that are licensed) that cannot afford to put them on. The...

4 months 1 week ago

AMP has agreed in principle to settle an advice and insurance class action that commenced in 2020 related to historic commission payment activity. ...

5 days 5 hours ago

Advice firms are increasing their base salaries by as much as $50k to attract talent, particularly seeking advisers with a portable book of clients, but equity offerings ...

3 weeks 4 days ago

ASIC has released the results of the latest financial adviser exam, held in November 2025....

1 week 4 days ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND
moneymanagement logo